[SRNE] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -92.89%
YoY- -25.42%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 20,407 121,910 4,665 4,874 4,019 2,243 902 695.39%
PBT -38,001 94,953 -16,137 -25,499 -12,724 14,031 -46,113 -12.07%
Tax -90,424 57,480 -1,398 -1,696 -701 -195 -1,164 1706.24%
NP 12,425 33,959 -14,187 -23,064 -11,957 14,373 -44,949 -
Tax Rate - -60.54% - - - 1.39% - -
Total Cost 7,982 87,951 18,852 27,938 15,976 -12,130 45,851 -68.72%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 60.89 27.86 -304.12 -473.20 -297.51 640.79 -4,983.26 -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS 0.15 0.44 -0.20 -0.45 -0.23 0.22 -0.97 -
EPS Diluted 0.15 0.44 -0.20 -0.45 -0.23 0.22 -0.97 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.